Early switch/early discharge opportunities for hospitalized patients with methicillin-resistant Staphylococcus aureus complicated skin and soft tissue infections in Brazil

Autor: Wing Yu Tang, Cynthia Macahilig, Courtney Johnson, Caitlyn T. Solem, Maria Lavínea Novis de Figueiredo, Richard Chambers, Jaime L. Rocha, Guilherme Henrique Campos Furtado, Seema Haider, Jennifer Stephens, Ricardo Hayden
Jazyk: angličtina
Rok vydání: 2019
Předmět:
Microbiology (medical)
Male
Methicillin-Resistant Staphylococcus aureus
medicine.medical_specialty
Time Factors
Economics
medicine.drug_class
medicine.medical_treatment
Antibiotics
lcsh:QR1-502
Administration
Oral

medicine.disease_cause
lcsh:Microbiology
lcsh:Infectious and parasitic diseases
03 medical and health sciences
Internal medicine
medicine
Humans
lcsh:RC109-216
Early discharge
Retrospective Studies
0303 health sciences
030306 microbiology
business.industry
Drug Substitution
IV-to-PO switch
Soft Tissue Infections
Clindamycin
Antibiotic therapy
Length of Stay
Middle Aged
Staphylococcal Infections
Methicillin-resistant Staphylococcus aureus
Patient Discharge
Anti-Bacterial Agents
Infectious Diseases
Intravenous therapy
Staphylococcus aureus
Clinical criteria
Length of stay
Vancomycin
Administration
Intravenous

Female
Staphylococcal Skin Infections
Daptomycin
business
Brazil
medicine.drug
Zdroj: Brazilian Journal of Infectious Diseases, Vol 23, Iss 2, Pp 86-94 (2019)
Brazilian Journal of Infectious Diseases, Volume: 23, Issue: 2, Pages: 86-94, Published: 18 JUL 2019
Brazilian Journal of Infectious Diseases v.23 n.2 2019
Brazilian Journal of Infectious Diseases
Brazilian Society of Infectious Diseases (BSID)
instacron:BSID
ISSN: 1413-8670
Popis: Background: Early antibiotic switch and early discharge protocols have not been widely studied in Latin America. Our objective was to describe real-world treatment patterns, resource use, and estimate opportunities for early switch from intravenous to oral antibiotics and early discharge for patients hospitalized with methicillin-resistant Staphylococcus aureus complicated skin and soft-tissue infections. Materials/methods: This retrospective medical chart review recruited 72 physicians from Brazil to collect data from patients hospitalized with documented methicillin-resistant Staphylococcus aureus complicated skin and soft tissue infections between May 2013 and May 2015, and discharged alive by June 2015. Data collected included clinical characteristics and outcomes, hospital length of stay, methicillin-resistant Staphylococcus aureus-targeted intravenous and oral antibiotic use, and early switch and early discharge eligibility using literature-based and expert-validated criteria. Results: A total of 199 patient charts were reviewed, of which 196 (98.5%) were prescribed methicillin-resistant Staphylococcus aureus -active therapy. Only four patients were switched from intravenous to oral antibiotics while hospitalized. The mean length of methicillin-resistant Staphylococcus aureus-active treatment was 14.7 (standard deviation, 10.1) days, with 14.6 (standard deviation, 10.1) total days of intravenous therapy. The mean length of hospital stay was 22.2 (standard deviation, 23.0) days. The most frequent initial methicillin-resistant Staphylococcus aureus-active therapies were intravenous vancomycin (58.2%), intravenous clindamycin (19.9%), and intravenous daptomycin (6.6%). Thirty-one patients (15.6%) were discharged with methicillin-resistant Staphylococcus aureus -active antibiotics of which 80.6% received oral antibiotics. Sixty-two patients (31.2%) met early switch criteria and potentially could have discontinued intravenous therapy 6.8 (standard deviation, 7.8) days sooner, and 65 patients (32.7%) met early discharge criteria and potentially could have been discharged 5.3 (standard deviation, 7.0) days sooner. Conclusions: Only 2% of patients were switched from intravenous to oral antibiotics in our study while almost one-third were early switch eligible. Additionally, one-third of hospitalized patients with methicillin-resistant Staphylococcus aureus complicated skin and soft tissue infections were early discharge eligible indicating opportunity for reducing intravenous therapy and days of hospital stay. These results provide insight into possible benefits of implementation of early switch/early discharge protocols in Brazil. Keywords: IV-to-PO switch, Length of stay, Clinical criteria, Antibiotic therapy, Economics
Databáze: OpenAIRE